April 4, 2025 - 09:43

The North Carolina Senate and House of Representatives are currently at an impasse regarding strategies to reduce health care costs and improve accessibility for residents. Central to this debate is the contentious issue of prior authorization, a process that many argue can hinder timely access to necessary medical treatments.
The Senate has proposed measures aimed at streamlining the prior authorization process, which they believe will alleviate delays in patient care. Conversely, the House is advocating for a more comprehensive approach that includes additional reforms intended to lower overall health care expenses.
As lawmakers engage in discussions, the implications of their decisions could significantly impact the lives of many North Carolinians. Advocates for health care reform are closely monitoring the situation, emphasizing the urgent need for solutions that prioritize patient well-being while balancing the interests of providers and insurers. The outcome of this legislative battle will be critical in shaping the future of health care in the state.
April 19, 2026 - 00:02
IMG Academy, Neuro Challenge Foundation host Parkinson’s wellness event focused on movement and brain healthA unique event at IMG Academy is helping people with Parkinson’s disease stay active while raising awareness about the importance of movement and community support. The recent wellness gathering...
April 18, 2026 - 04:30
\'It\'s personal to me\': Bill requiring mental health awareness training for coaches passes in state HouseA bill requiring mental health awareness training for school athletics staff is headed to the Pennsylvania Senate after passing in the state House on Wednesday. The proposed legislation, which...
April 17, 2026 - 03:07
New Leadership Nominated for the Centers for Disease Control and PreventionIn a move to stabilize a key public health agency, Erica Schwartz has been nominated to serve as the next director of the Centers for Disease Control and Prevention. The nomination comes at a...
April 16, 2026 - 02:18
RFK Jr. promotes peptides. Now the FDA weighs easing limits on the unproven chemicalsThe U.S. Food and Drug Administration is moving to re-evaluate its stance on a group of unapproved chemicals known as peptides, following a surge in public interest and promotion by high-profile...